Bausch Health Companies Inc.

BHC · Healthcare · Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company

Bausch Health Companies Inc. (BHC), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 1 purchase and 2 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Aug 19 and filed Aug 20. The most active filer was John Paulson with 4 filings.

Add to watchlist

Filings, ttm

1 buy · 2 sells

Traders, ttm

3 insiders

Volume, ttmiDollar value disclosed in the window

$16.0M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 19

Filed Aug 20

ADViAverage daily dollar volume

$23.4M

market data

Share price · 12M

$6.51 (-4.4%)

Adjusted for splits and dividends.

Volume by month

Buys $385.3M Sells $514K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

John Paulson Director 4 filings FL

Frank D. Lee Director 2 filings AL

Aimee J. Lenar President, US Pharma 1 filing PI Paulson & Co. Inc. Other 1 filing

Recent filings

Aimee J. LenarSALE President, US Pharma $259K
36,827 sh × $7.03
Exec Aug 19
Filed Aug 20 · 4:33 PM ET Frank D. LeeSALE Director $133K
24,456 sh × $5.43
Exec May 19
Filed May 20 · 5:30 PM ET Paulson & Co. Inc.PURCHASE 10% owner $15.6M
2,500,000 sh × $6.25
Exec Nov 25 2025
Filed Nov 28 2025 · 5:38 PM ET Frank D. LeeSALE Director $122K
15,912 sh × $7.66
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET John PaulsonPURCHASE Director $312.5M
34,721,118 sh × $9.00
Exec Aug 14 2025
Filed Aug 14 2025 · 9:35 PM ET John PaulsonPURCHASE Director $21.3M
3,243,049 sh across 3 lots
Exec Aug 11 2025
Filed Aug 13 2025 · 6:51 PM ET John PaulsonPURCHASE Director $21.2M
3,564,059 sh × $5.94
Exec Jun 13 2025
Filed Jun 17 2025 · 5:30 PM ET John PaulsonPURCHASE Director $14.7M
2,788,608 sh across 3 lots
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET